Enveric Accounts Payable from 2010 to 2024

ENVB Stock  USD 0.33  0.01  3.13%   
Enveric Biosciences' Accounts Payable is decreasing over the years with stable fluctuation. Overall, Accounts Payable is expected to go to about 1.3 M this year. Accounts Payable is the amount Enveric Biosciences owes to suppliers or vendors for products or services received but not yet paid for. It represents Enveric Biosciences' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1994-06-30
Previous Quarter
459.9 K
Current Value
576.3 K
Quarterly Volatility
1.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Enveric Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enveric Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 327, Interest Expense of 3.5 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.33, Dividend Yield of 475.8 K or PTB Ratio of 1.36. Enveric financial statements analysis is a perfect complement when working with Enveric Biosciences Valuation or Volatility modules.
  
Check out the analysis of Enveric Biosciences Correlation against competitors.
For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.

Latest Enveric Biosciences' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Enveric Biosciences over the last few years. An accounting item on the balance sheet that represents Enveric Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Enveric Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Enveric Biosciences' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enveric Biosciences' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Pretty Stable
   Accounts Payable   
       Timeline  

Enveric Accounts Payable Regression Statistics

Arithmetic Mean2,648,107
Geometric Mean1,846,847
Coefficient Of Variation80.09
Mean Deviation1,536,009
Median2,597,386
Standard Deviation2,120,785
Sample Variance4.5T
Range7.6M
R-Value(0.17)
Mean Square Error4.7T
R-Squared0.03
Significance0.55
Slope(78,833)
Total Sum of Squares63T

Enveric Accounts Payable History

20241.3 M
20231.2 M
2022463.3 K
2021683.4 K
2020681.2 K
20194.7 M
20184.4 M

About Enveric Biosciences Financial Statements

Enveric Biosciences stakeholders use historical fundamental indicators, such as Enveric Biosciences' Accounts Payable, to determine how well the company is positioned to perform in the future. Although Enveric Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Enveric Biosciences' assets and liabilities are reflected in the revenues and expenses on Enveric Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Enveric Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable1.2 M1.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Enveric Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enveric Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enveric Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enveric Biosciences Stock:
Check out the analysis of Enveric Biosciences Correlation against competitors.
For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. If investors know Enveric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enveric Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.42)
Revenue Per Share
37.678
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.81)
Return On Equity
(2.06)
The market value of Enveric Biosciences is measured differently than its book value, which is the value of Enveric that is recorded on the company's balance sheet. Investors also form their own opinion of Enveric Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Enveric Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enveric Biosciences' market value can be influenced by many factors that don't directly affect Enveric Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enveric Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enveric Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enveric Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.